CONTRIBUTED SURPLUS-WARRANT RESERVE |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contributed Surplus [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CONTRIBUTED SURPLUS-WARRANT RESERVE |
7.CONTRIBUTED SURPLUS-WARRANT RESERVE The Company issued warrants pursuant to the equity offerings in 2020 and 2021. Each warrant entitled the holder to purchase one common share at a fixed price, these warrants were classified as equity under IAS 32. These equity warrants expire between February 24, 2023 and January 26, 2026 and are not revalued at each reporting period. As at September 30, 2022, the following equity warrants were outstanding:
|